About Dr Danijela Gnjidic

Geriatric pharmacology Quality use of medicines Pharmacoepidemiology

Dr Danijela Gnjidic is a NHMRC Dementia Leadership Fellow and Senior Lecturer at the Faculty of Pharmacy, University of Sydney. Her research expertise is in clinical and geriatric pharmacology, clinical studies on polypharmacy, high risk prescribing, and deprescribing (drug withdrawal) in older people, pharmacoepidemiology, and the quality use of medicines. Danijela completed her doctoral training at the University of Sydney in 2010. She also undertook and completed a Masters of Public Health, concurrently with her PhD. Following her doctoral training, Danijela conducted post-doctoral training at the University of Eastern Finland where she furthered her geriatric pharmacology and pharmacoepidemiology research

http://sydney.edu.au/pharmacy/about/people/profiles/danijela.gnjidic.php

Epidemiology; Pharmacology; Ageing

Selected publications

Book Chapters
Hilmer, S., Gnjidic, D. (2016). Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people. In Sven Stegemann (Eds.), Developing Drug Products in an Aging Society: From concept to prescribing, (pp. 171-188). Switzerland: Springer. [More Information]Hilmer, S., Gnjidic, D. (2014). Frailty. In Gideon Kaplan (Eds.), Geriatric Medicine: An Introduction, (pp. 189-201). Melbourne: IP Communications.
Journals
Moga, D., Taipale, H., Tolppanen, A., Tanskanen, A., Tiihonen, J., Hartikainen, S., Wu, Q., Jicha, G., Gnjidic, D. (2017). A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Drugs and Aging, 34(1), 55-65. [More Information]Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., Gnjidic, D. (2017). A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. European Journal of Clinical Pharmacology, 73(8), 927-935. [More Information]Kouladjian O'Donnell, L., Gnjidic, D., Nahas, R., Bell, J., Hilmer, S. (2017). Anticholinergic burden: Considerations for older adults. Journal of Pharmacy Practice and Research, 47(1), 67-77. [More Information]Gnjidic, D., Du, W., Pearson, S., Hilmer, S., Banks, E. (2017). Ascertainment of self-reported prescription medication use compared with pharmaceutical claims data. Public Health Research and Practice, 27(4), 1-7. [More Information]Gnjidic, D., Tinetti, M., Allore, H. (2017). Assessing medication burden and polypharmacy: finding the perfect measure. Expert Review of Clinical Pharmacology, 10(4), 345-347. [More Information]Peeters, G., Tett, S., Hollingworth, S., Gnjidic, D., Hilmer, S., Dobson, A., Hubbard, R. (2017). Associations of Guideline Recommended Medications for Acute Coronary Syndromes With Fall-Related Hospitalizations and Cardiovascular Events in Older Women With Ischemic Heart Disease. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 72(2), 259-265. [More Information]Fiona-Maree Gilmartin, J., Gnjidic, D. (2017). Complementing or expanding on existing areas of research expertise: The importance of attending and organising conferences in specific clinical areas. Research in Social and Administrative Pharmacy, 13(3), 656-657. [More Information]Jamsen, K., Gnjidic, D., Hilmer, S., Ilomaki, J., Le Couteur, D., Blyth, F., Handelsman, D., Naganathan, V., Waite, L., Cumming, R., et al (2017). Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study. Annals of Medicine, 49(2), 157-164. [More Information]McAvay, G., Allore, H., Cohen, A., Gnjidic, D., Murphy, T., Tinetti, M. (2017). Guideline-Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions. Journal of the American Geriatrics Society, 65(12), 2619-2626. [More Information]